EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

Raphael G.; Taveras H.; Iverson H.; OBrien C.; Miller D.

首页> 外文期刊>Annals of allergy, asthma, and immunology >EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

【24h】

EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

机译：沙丁胺醇多剂量干粉吸入器对PLACEBO在12岁及以上患有持续性哮喘的受试者中的疗效。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of allergy, asthma, and immunology》 |2014年第1期|共2页
作者
Raphael G.; Taveras H.; Iverson H.; OBrien C.; Miller D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA. [J] . Raphael G., Taveras H., Iverson H., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：沙丁胺醇多剂量干粉吸入器对PLACEBO在12岁及以上患有持续性哮喘的受试者中的疗效。
2. CUMULATIVE DOSE COMPARISON OF THE EFFICACY AND SAFETY OF ALBUTEROL-MULTIDOSE DRY POWDER INHALER AND ALBUTEROL-HYDROFLUOROALKANE METERED DOSE INHALER IN ADULTS WITH ASTHMA. [J] . Miller D., Wayne D., Ferro T., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：哮喘患者中沙丁胺醇多剂量干粉吸入器和沙丁胺醇-氢氟烷烃计量剂量吸入器疗效和安全性的累积剂量比较。
3. ALBUTEROL MULTIDOSE DRY POWDER INHALER IN PATIENTS 12 YEARS AND OLDER WITH PERSISTENT ASTHMA: 12 AND 52 WEEK SAFETY. [J] . LaForce C., Miller D., Taveras H., Annals of allergy, asthma, and immunology . 2014,第5Suppla1期

机译：患有哮喘的12岁及以上患者的阿尔布特罗多剂量干粉吸入器：安全12周和52周。
4. THE EFFICACY OF A NEW ALBUTEROL METERED DOSE POWDER INHALER IN COMPARISON WITH TWO OTHER INHALER DEVICES [C] . Seppaelae, O-P., Aalto, International symposium on controlled release of bioactive materials;Consumer diversified products conference . 2001

机译：新型沙丁胺醇计量剂量粉末吸入器与其他两种吸入器设备的功效
5. Twelve- and 52-week safety of albuterol multidose dry powder inhaler in patients with persistent asthma [O] . Gordon Raphael, Herminia Taveras, Harald Iverson, -1

机译：沙丁胺醇多剂量干粉吸入器在持续性哮喘患者中的12周和52周安全性
6. Dose-Ranging Efficacy and Safety Study of Albuterol Multidose Dry Powder Inhaler (MDPI) vs Albuterol Hydrofluoroalkane (HFA) and Placebo MDPI in Children With Asthma [O] . Paul Y. Qaqundah, Herminia Taveras, Harald Iverson, 2016

机译：患有哮喘患儿的Albuterol多糖干粉吸入器（MDPI）与哮喘儿童的安慰剂MDPI的剂量 - 测量疗效和安全性研究

EFFICACY OF ALBUTEROL MULTIDOSE DRY POWDER INHALER VERSUS PLACEBO IN SUBJECTS 12 YEARS OF AGE AND OLDER WITH PERSISTENT ASTHMA.

著录项

相似文献

相关主题

期刊订阅